Genome Editing in Human iPS Cells to Study and Cure Disease
Human iPS (induced pluripotent stem) cells have the potential to allow us to study diseases in virtually any type of human cell, and develop cell transplantation-based therapies. Our team is developing and improving genome editing technology in iPS cells. We are developing novel isogenic iPS cell-based disease models, and correcting mutations in iPS cells from patients, a critical step in transplantation-based therapies. Our current focus is on diseases affecting cardiomyocytes and hepatocytes. →More
2023. 8. 7. Moe Sato joins the lab as an Intern!
2023. 8. 4. Lab trip to Akigawa valley.
2023. 7. 10. Grace joins the lab as a Summer Intern!
2023. 6. 28. Video Clip of Our Daily Lab Life Is Out!
2023. 6. 16. Ittetsu Nakajima is awarded the Takuetsu Fellowship!!
2023. 6. 15. Seminar presented at ddPCR World 2023 (6/9) is now accessible online (3rd plenary talk).
2023. 2. 27&28. Lab ski trip to Madarao
2023. 2. 21. Lab introductory video is out (only in Japanese)!
2022. 11. 25. Lab trip to Mt. Takao
2023. 11. 29. Kumamoto University Liaison Lab / HIGO Program Seminar (Talk in English)
2024. 6. 2-4. 8th International Update on Fabry Disease @ Hamburg (Talk)